Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 4 of 100
Tech
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
By
Ryan Hogg
March 25, 2025
Tech
AstraZeneca to buy cell therapy biotech for up to $1 billion
By
Ashleigh Furlong
and
Bloomberg
March 17, 2025
Commentary
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By
Michelle Werner
March 10, 2025
Commentary
The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By
Wendy Barnes
March 4, 2025
Leadership
A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By
Lila MacLellan
March 1, 2025
Health
GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
By
Ryan Hogg
February 28, 2025
Finance
Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
By
Madison Muller
and
Bloomberg
February 26, 2025
Leadership
Bayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a runaway bureaucracy
By
Fortune Editors
February 26, 2025
Health
With RFK Jr. in charge, supplement makers see chance to cash in
By
KFF Health News
and
Arthur Allen
February 25, 2025
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By
Bloomberg
,
Madison Muller
,
Ike Swetlitz
and
Naomi Kresge
February 21, 2025
Finance
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By
Ryan Hogg
February 19, 2025
Health
Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
By
Lindsey Leake
February 15, 2025
Health
Experts sound the alarm as Ohio farmworker’s bird flu sparks fear it’s the next pandemic
By
Lindsey Leake
February 13, 2025
Health
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By
Lindsey Leake
February 11, 2025
Health
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By
Lindsey Leake
February 7, 2025
Most Popular
Retail
Trump just declared Christmas Eve a national holiday. Here’s what’s open and closed
By
Dave Smith
Personal Finance
Trump turns government into giant debt collector with threat to garnish wages on millions of Americans in default on...
By
Annie Ma
and
The Associated Press
Economy
Obama's former top economic advisor says he feels 'a tiny bit bad' for Trump because gas prices are low, but consumer...
By
Sasha Rogelberg